Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001967150-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 10, 2026 |
| Document Date | Feb 6, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
5,000
Total Value
$145,219.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF SCIENTIFIC OFFICER | Common Stock | โ | Feb 6, 2026 | Sale | 5,000 | $29.04 | $145,219.00 | 740,188 | Indirect | See footnote | View Details |